A new report titled “Cell Therapy Market – Forecast to 2033” by Eternal Markets, the global cell therapy industry is projected to grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2033, reaching a value of USD 11,345.0 million by the end of the forecast period.
Overview
The global cell therapy market is experiencing significant growth, driven by the increasing adoption of regenerative medicine and advanced therapies for the treatment of various diseases. Cell therapy involves the use of living cells to repair or replace damaged tissues and organs, and it has applications in oncology, cardiology, orthopedics, and neurology. The market growth is fueled by advancements in cell-based research, increasing investment in regenerative medicine, and rising prevalence of chronic diseases. The growing focus on personalized medicine and the development of innovative cell therapy products are also contributing to market expansion. North America and Europe are leading markets due to strong research and development activities and advanced healthcare infrastructure.
Key Visions
- The global cell therapy market is projected to grow at a CAGR of around 11.2% over the forecast period (2024-2033).
- The global cell therapy industry size is projected to reach USD 11,345.0 million by 2033 from USD 4,230.5 million in 2023.
- The growing incidence of chronic conditions such as cancer, cardiovascular diseases, and autoimmune disorders drives the demand for cell therapy.
- By therapy type, in 2023, Autologous therapy segment held largest market share.
- Based on indication, oncology segment likely to be the largest revenue contributor in 2033.
- North America held the largest market share in 2023 due to its advanced healthcare infrastructure and high adoption of innovative technologies in the countries of the region.
Key Market Drivers
Rising Prevalence of Chronic Diseases: The growing incidence of chronic conditions such as cancer, cardiovascular diseases, and autoimmune disorders drives the demand for cell therapy.
Advancements in Regenerative Medicine: Continuous advancements in stem cell research and regenerative medicine are expanding the applications of cell therapy.
Increasing R&D Investments: Significant investments in research and development by government bodies and private companies are accelerating the development of new cell therapies.
Supportive Regulatory Environment: Favorable regulatory policies and accelerated approval processes for advanced therapies are facilitating market growth.
Growing Adoption of Autologous Therapies: Increasing preference for autologous therapies due to lower risk of immune rejection and better patient outcomes.
Restraining Factors
High Treatment Costs: The high cost of cell therapy treatments poses a significant barrier to widespread adoption.
Complex Manufacturing Processes: The complex and stringent manufacturing processes required for cell therapies can limit production capacity and scalability.
Regulatory Challenges: Navigating the regulatory landscape for cell therapies is complex and can delay product approvals.
Future Scope
Expansion into Emerging Markets: Significant growth potential in emerging markets due to improving healthcare infrastructure and increasing healthcare expenditure.
Development of Novel Therapies: Ongoing research and development activities are expected to lead to the introduction of novel cell therapies for various indications.
Personalized Medicine: Growing focus on personalized medicine and tailored treatments will drive the adoption of cell therapies.
Integration with Gene Therapy: Combining cell therapy with gene therapy to enhance therapeutic outcomes and treat complex diseases.
Technological Advancements: Innovations in cell manufacturing technologies and delivery methods will improve the efficacy and accessibility of cell therapies.
Major Strategies adopted by key market players.
- Agreements, Collaborations, and Partnerships: 21%
- Acquisitions: 15%
- New Product Launch: _%
- Other Developments: _%
Geographical Analysis
North America: North America is the largest market for cell therapy, driven by advanced healthcare infrastructure, high adoption rates of innovative therapies, and strong research and development activities. The U.S. is the major contributor to the market in this region.
Europe: Europe holds a significant market share due to robust healthcare systems, increasing prevalence of chronic diseases, and strong focus on research and development. Countries like Germany, the U.K., and France are key markets.
Asia-Pacific: Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by improving healthcare infrastructure, increasing healthcare expenditure, and growing awareness about advanced therapies. China, Japan, and India are major contributors to the market in this region.
Recent Developments
Bristol-Myers Squibb Company: Acquired a leading cell therapy company in 2023 to expand its product portfolio and market reach.
Novartis AG: Launched a new CAR-T cell therapy for cancer treatment in 2022.
Johnson & Johnson Services, Inc: Partnered with a biotech firm in 2023 to develop next-generation cell therapies.
Gilead Sciences, Inc.: Expanded its cell therapy manufacturing capabilities with a new facility in 2022.
Scope of the Report:
Global Cell Therapy Market, By Therapy Type
- Autologous Therapies
- Stem Cell Therapies
- Non-Stem Cell Therapies
- Allogeneic Therapies
- Stem Cell Therapies
- Non-Stem Cell Therapies
Global Cell Therapy Market, By Indication Type
- Oncology
- Cardiovascular Disease (CVD)
- Musculoskeletal Disorders
- Dermatology
- Others
Global Cell Therapy Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
● Bristol-Myers Squibb Company
● Novartis AG
● Johnson & Johnson Services, Inc
● JCR Pharmaceuticals Co., Ltd.
● Gilead Sciences, Inc.
● JW Therapeutics
● Atara Biotherapeutics
● MEDIPOST
● S. BIOMEDICS
● Anterogen Co., Ltd.
● Other key players
*The report scope shall be customized as per the requirements
Chapter 1 Global Cell Therapy Market Overview
1.1 Introduction
1.2 Drivers for Cell Therapy Market
1.3 Restraints for Cell Therapy Market
1.4 Opportunities for Cell Therapy Market
1.5 Trends for Cell Therapy Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Cell Therapy Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Bristol-Myers Squibb Company
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Novartis AG
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Johnson & Johnson Services, Inc
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 JCR Pharmaceuticals Co., Ltd.
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Gilead Sciences, Inc.
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 JW Therapeutics
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Atara Biotherapeutics
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 MEDIPOST
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 S. BIOMEDICS
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Anterogen Co., Ltd.
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Cell Therapy Market Overview
3.1 Global Cell Therapy Market Outlook (2017-2032)
3.1.1 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Cell Therapy Market by Region
3.2.1 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Cell Therapy Market by Therapy Type
3.3.1 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2032)
3.3.2 Global Cell Therapy Market Attractiveness Analysis by Therapy Type, 2023–2032
3.3.3 Global Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Cell Therapy Market by Indication Type
3.4.1 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2032)
3.4.2 Global Cell Therapy Market Attractiveness Analysis by Indication Type, 2023–2032
3.5 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) by Therapy Type
3.6.1 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2023)
3.6.2 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2024-2032)
3.7 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) by Indication Type
3.7.1 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2023)
3.7.2 Global Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2024-2032)
3.8 Global Cell Therapy Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Cell Therapy Market Y-o-Y Growth Rate by Region
3.8.2 Global Cell Therapy Market Y-o-Y Growth Rate by Therapy Type
3.8.3 Global Cell Therapy Market Y-o-Y Growth Rate by Indication Type
3.9 Global Cell Therapy Market Share Comparison 2017–2032
3.9.1 Global Cell Therapy Market Share by Region
3.9.2 Global Cell Therapy Market Share by Therapy Type
3.9.3 Global Cell Therapy Market Share by Indication Type
Chapter 4 North America Cell Therapy Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Cell Therapy Market Outlook (2017-2032)
4.2.1 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Cell Therapy Market by Region
4.3.1 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Cell Therapy Market by Therapy Type
4.4.1 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2032)
4.4.2 North America Cell Therapy Market Attractiveness Analysis by Therapy Type, 2023–2032
4.4.3 North America Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Cell Therapy Market by Indication Type
4.5.1 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2032)
4.5.2 North America Cell Therapy Market Attractiveness Analysis by Indication Type, 2023–2032
4.6 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) by Therapy Type
4.7.1 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2023)
4.7.2 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2024-2032)
4.8 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) by Indication Type
4.8.1 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2023)
4.8.2 North America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2024-2032)
4.9 North America Cell Therapy Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Cell Therapy Market Y-o-Y Growth Rate by Region
4.9.2 North America Cell Therapy Market Y-o-Y Growth Rate by Therapy Type
4.9.3 North America Cell Therapy Market Y-o-Y Growth Rate by Indication Type
4.1 North America Cell Therapy Market Share Comparison 2017–2032
4.10.1 North America Cell Therapy Market Share by Region
4.10.2 North America Cell Therapy Market Share by Therapy Type
4.10.3 North America Cell Therapy Market Share by Indication Type
Chapter 5 Europe Cell Therapy Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Cell Therapy Market Outlook (2017-2032)
5.2.1 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Cell Therapy Market by Region
5.3.1 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Cell Therapy Market by Therapy Type
5.4.1 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2032)
5.4.2 Europe Cell Therapy Market Attractiveness Analysis by Therapy Type, 2023–2032
5.4.3 Europe Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Cell Therapy Market by Indication Type
5.5.1 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2032)
5.5.2 Europe Cell Therapy Market Attractiveness Analysis by Indication Type, 2023–2032
5.6 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) by Therapy Type
5.7.1 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2023)
5.7.2 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2024-2032)
5.8 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) by Indication Type
5.8.1 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2023)
5.8.2 Europe Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2024-2032)
5.9 Europe Cell Therapy Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Cell Therapy Market Y-o-Y Growth Rate by Region
5.9.2 Europe Cell Therapy Market Y-o-Y Growth Rate by Therapy Type
5.9.3 Europe Cell Therapy Market Y-o-Y Growth Rate by Indication Type
5.1 Europe Cell Therapy Market Share Comparison 2017–2032
5.10.1 Europe Cell Therapy Market Share by Region
5.10.2 Europe Cell Therapy Market Share by Therapy Type
5.10.3 Europe Cell Therapy Market Share by Indication Type
Chapter 6 Asia Pacific Cell Therapy Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Cell Therapy Market Outlook (2017-2032)
6.2.1 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Cell Therapy Market by Region
6.3.1 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Cell Therapy Market by Therapy Type
6.4.1 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2032)
6.4.2 Asia Pacific Cell Therapy Market Attractiveness Analysis by Therapy Type, 2023–2032
6.4.3 Asia Pacific Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Cell Therapy Market by Indication Type
6.5.1 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2032)
6.5.2 Asia Pacific Cell Therapy Market Attractiveness Analysis by Indication Type, 2023–2032
6.6 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) by Therapy Type
6.7.1 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2023)
6.7.2 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2024-2032)
6.8 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) by Indication Type
6.8.1 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2023)
6.8.2 Asia Pacific Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2024-2032)
6.9 Asia Pacific Cell Therapy Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Cell Therapy Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Cell Therapy Market Y-o-Y Growth Rate by Therapy Type
6.9.3 Asia Pacific Cell Therapy Market Y-o-Y Growth Rate by Indication Type
6.1 Asia Pacific Cell Therapy Market Share Comparison 2017–2032
6.10.1 Asia Pacific Cell Therapy Market Share by Region
6.10.2 Asia Pacific Cell Therapy Market Share by Therapy Type
6.10.3 Asia Pacific Cell Therapy Market Share by Indication Type
Chapter 7 South America Cell Therapy Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Cell Therapy Market Outlook (2017-2032)
7.2.1 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Cell Therapy Market by Region
7.3.1 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Cell Therapy Market by Therapy Type
7.4.1 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2032)
7.4.2 South America Cell Therapy Market Attractiveness Analysis by Therapy Type, 2023–2032
7.4.3 South America Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Cell Therapy Market by Indication Type
7.5.1 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2032)
7.5.2 South America Cell Therapy Market Attractiveness Analysis by Indication Type, 2023–2032
7.6 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) by Therapy Type
7.7.1 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2023)
7.7.2 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2024-2032)
7.8 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) by Indication Type
7.8.1 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2023)
7.8.2 South America Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2024-2032)
7.9 South America Cell Therapy Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Cell Therapy Market Y-o-Y Growth Rate by Region
7.9.2 South America Cell Therapy Market Y-o-Y Growth Rate by Therapy Type
7.9.3 South America Cell Therapy Market Y-o-Y Growth Rate by Indication Type
7.1 South America Cell Therapy Market Share Comparison 2017–2032
7.10.1 South America Cell Therapy Market Share by Region
7.10.2 South America Cell Therapy Market Share by Therapy Type
7.10.3 South America Cell Therapy Market Share by Indication Type
Chapter 8 Middle East and Africa Cell Therapy Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Cell Therapy Market Outlook (2017-2032)
8.2.1 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Cell Therapy Market by Region
8.3.1 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Cell Therapy Market by Therapy Type
8.4.1 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2032)
8.4.2 Middle East and Africa Cell Therapy Market Attractiveness Analysis by Therapy Type, 2023–2032
8.4.3 Middle East and Africa Cell Therapy Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Cell Therapy Market by Indication Type
8.5.1 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2032)
8.5.2 Middle East and Africa Cell Therapy Market Attractiveness Analysis by Indication Type, 2023–2032
8.6 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) by Therapy Type
8.7.1 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2017-2023)
8.7.2 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Therapy Type (2024-2032)
8.8 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) by Indication Type
8.8.1 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2017-2023)
8.8.2 Middle East and Africa Cell Therapy Market Value (US$ Mn) and Volume (Units) Comparison by Indication Type (2024-2032)
8.9 Middle East and Africa Cell Therapy Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Cell Therapy Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Cell Therapy Market Y-o-Y Growth Rate by Therapy Type
8.9.3 Middle East and Africa Cell Therapy Market Y-o-Y Growth Rate by Indication Type
8.1 Middle East and Africa Cell Therapy Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Cell Therapy Market Share by Region
8.10.2 Middle East and Africa Cell Therapy Market Share by Therapy Type
8.10.3 Middle East and Africa Cell Therapy Market Share by Indication Type
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
